title: Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
abstract: BACKGROUND
  X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency with high morbidity and mortality compared with those seen in healthy subjects. Hematopoietic cell transplantation (HCT) has been considered a curative therapy, but the procedure has inherent complications and might not be available for all patients.
  
  
  OBJECTIVE
  We sought to collect data on the clinical presentation, treatment, and follow-up of a large sample of patients with XHIGM to (1) compare long-term overall survival and general well-being of patients treated with or without HCT along with clinical factors associated with mortality and (2) summarize clinical practice and risk factors in the subgroup of patients treated with HCT.
  
  
  METHODS
  Physicians caring for patients with primary immunodeficiency diseases were identified through the Jeffrey Modell Foundation, United States Immunodeficiency Network, Latin American Society for Immunodeficiency, and Primary Immune Deficiency Treatment Consortium. Data were collected with a Research Electronic Data Capture Web application. Survival from time of diagnosis or transplantation was estimated by using the Kaplan-Meier method compared with log-rank tests and modeled by using proportional hazards regression.
  
  
  RESULTS
  Twenty-eight clinical sites provided data on 189 patients given a diagnosis of XHIGM between 1964 and 2013; 176 had valid follow-up and vital status information. Sixty-seven (38%) patients received HCT. The average follow-up time was 8.5 ± 7.2 years (range, 0.1-36.2 years). No difference in overall survival was observed between patients treated with or without HCT (P = .671). However, risk associated with HCT decreased for diagnosis years 1987-1995; the hazard ratio was significantly less than 1 for diagnosis years 1995-1999. Liver disease was a significant predictor of overall survival (hazard ratio, 4.9; 95% confidence limits, 2.2-10.8; P < .001). Among survivors, those treated with HCT had higher median Karnofsky/Lansky scores than those treated without HCT (P < .001). Among patients receiving HCT, 27 (40%) had graft-versus-host disease, and most deaths occurred within 1 year of transplantation.
  
  
  CONCLUSIONS
  No difference in survival was observed between patients treated with or without HCT across all diagnosis years (1964-2013). However, survivors treated with HCT experienced somewhat greater well-being, and hazards associated with HCT decreased, reaching levels of significantly less risk in the late 1990s. Among patients treated with HCT, treatment at an early age is associated with improved survival. Optimism remains guarded as additional evidence accumulates.
authors.affiliation: University of Texas Southwestern Medical Center and Children's Medical Center, Children's Health, Dallas, Tex. Electronic address: maite.delamorena@utsouthwestern.edu.
authors.forename: M Teresa
authors.initials: MT
authors.lastname: de la Morena
authors.affiliation: University of Texas Southwestern Medical Center and Children's Medical Center, Children's Health, Dallas, Tex.
authors.forename: David
authors.initials: D
authors.lastname: Leonard
authors.affiliation: University of Washington and Seattle Children's Research Institute, Seattle, Wash.
authors.forename: Troy R
authors.initials: TR
authors.lastname: Torgerson
authors.affiliation: Department of Rheumatology, University of Lübeck, Lübeck, Germany.
authors.forename: Otavio
authors.initials: O
authors.lastname: Cabral-Marques
authors.affiliation: Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
authors.forename: Mary
authors.initials: M
authors.lastname: Slatter
authors.affiliation: Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Asghar
authors.initials: A
authors.lastname: Aghamohammadi
authors.affiliation: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
authors.forename: Sharat
authors.initials: S
authors.lastname: Chandra
authors.affiliation: Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Luis
authors.initials: L
authors.lastname: Murguia-Favela
authors.affiliation: Boston Children's Hospital, Boston, Mass.
authors.forename: Francisco A
authors.initials: FA
authors.lastname: Bonilla
authors.affiliation: Sophia Children's Hospital Athens, Athens, Greece.
authors.forename: Maria
authors.initials: M
authors.lastname: Kanariou
authors.affiliation: University of South Florida, All Childrens FL, St Petersburg, Fla.
authors.forename: Rongras
authors.initials: R
authors.lastname: Damrongwatanasuk
authors.affiliation: Geffen SOM at David Geffen School of Medicine at UCLA, Los Angeles, Calif.
authors.forename: Caroline Y
authors.initials: CY
authors.lastname: Kuo
authors.affiliation: UC San Francisco, San Francisco, Calif.
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Dvorak
authors.affiliation: University Hospitals Leuven, Leuven, Belgium.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Meyts
authors.affiliation: University of Utah School of Medicine, Salt Lake City, Utah.
authors.forename: Karin
authors.initials: K
authors.lastname: Chen
authors.affiliation: Emory University, Atlanta, Ga.
authors.forename: Lisa
authors.initials: L
authors.lastname: Kobrynski
authors.affiliation: Children's Hospital Los Angeles, Keck School of Medicine, Los Angeles, Calif.
authors.forename: Neena
authors.initials: N
authors.lastname: Kapoor
authors.affiliation: University Hospital Center, Zagreb, Croatia.
authors.forename: Darko
authors.initials: D
authors.lastname: Richter
authors.affiliation: Hospital de Niños Dr Ricardo Gutierrez, Buenos Aires, Argentina.
authors.forename: Daniela
authors.initials: D
authors.lastname: DiGiovanni
authors.affiliation: University of Oxford, Oxford, United Kingdom.
authors.forename: Fatima
authors.initials: F
authors.lastname: Dhalla
authors.affiliation: Ippokration General Hospital, Thessaloniki, Greece.
authors.forename: Evangelia
authors.initials: E
authors.lastname: Farmaki
authors.affiliation: Department of Pediatrics and Adolescent Medicine, Center for Chronic Immunodeficiency University Medical Center, Freiburg, Germany.
authors.forename: Carsten
authors.initials: C
authors.lastname: Speckmann
authors.affiliation: Hospital Vall d'Hebron, Barcelona, Spain.
authors.forename: Teresa
authors.initials: T
authors.lastname: Español
authors.affiliation: Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
authors.forename: Anna
authors.initials: A
authors.lastname: Shcherbina
authors.affiliation: Baylor/Texas Children's Hospital, Houston, Tex.
authors.forename: Imelda Celine
authors.initials: IC
authors.lastname: Hanson
authors.affiliation: Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
authors.forename: Jiri
authors.initials: J
authors.lastname: Litzman
authors.affiliation: Children's Hospital of Wisconsin, Milwaukee, Wis.
authors.forename: John M
authors.initials: JM
authors.lastname: Routes
authors.affiliation: Children's Hospital at Westmead, Sydney, Australia.
authors.forename: Melanie
authors.initials: M
authors.lastname: Wong
authors.affiliation: Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Ill.
authors.forename: Ramsay
authors.initials: R
authors.lastname: Fuleihan
authors.affiliation: Royal Free Hospital, London, United Kingdom.
authors.forename: Suranjith L
authors.initials: SL
authors.lastname: Seneviratne
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, NY.
authors.forename: Trudy N
authors.initials: TN
authors.lastname: Small
authors.affiliation: University Hospital Motol, Prague, Czech Republic.
authors.forename: Ales
authors.initials: A
authors.lastname: Janda
authors.affiliation: Hospital de Niños Dr Ricardo Gutierrez, Buenos Aires, Argentina.
authors.forename: Liliana
authors.initials: L
authors.lastname: Bezrodnik
authors.affiliation: Lucerne, Switzerland.
authors.forename: Reinhard
authors.initials: R
authors.lastname: Seger
authors.affiliation: Hospital de Niños Dr Ricardo Gutierrez, Buenos Aires, Argentina.
authors.forename: Andrea Gomez
authors.initials: AG
authors.lastname: Raccio
authors.affiliation: Regional Immunology Service, Belfast, United Kingdom.
authors.forename: J David M
authors.initials: JD
authors.lastname: Edgar
authors.affiliation: Children's Hospital Boston, Boston, Mass.
authors.forename: Janet
authors.initials: J
authors.lastname: Chou
authors.affiliation: National Jewish Health, Denver, Colo.
authors.forename: Jordan K
authors.initials: JK
authors.lastname: Abbott
authors.affiliation: Division Pediatrics, Pediatrische Immunologie en Infectieziekten, Wilhelmina Children's Hospital, UMC Utrecht, Utrecht, The Netherlands.
authors.forename: Joris
authors.initials: J
authors.lastname: van Montfrans
authors.affiliation: Unidad de Immunodeficiencias Primarias y la Unidad de Hematología y Oncología Pediátrica, Instituto de Investigacíon Hospital 12 de Octubre, Madrid, Spain.
authors.forename: Luis Ignacio
authors.initials: LI
authors.lastname: González-Granado
authors.affiliation: Children's Hospital of Philadelphia, Philadelphia, Pa.
authors.forename: Nancy
authors.initials: N
authors.lastname: Bunin
authors.affiliation: Ege University Faculty of Medicine, Izmir, Turkey.
authors.forename: Necil
authors.initials: N
authors.lastname: Kutukculer
authors.affiliation: Sydney Children's Hospital, Randwick, Australia.
authors.forename: Paul
authors.initials: P
authors.lastname: Gray
authors.affiliation: Hospital de Niños Dr Ricardo Gutierrez, Buenos Aires, Argentina.
authors.forename: Gisela
authors.initials: G
authors.lastname: Seminario
authors.affiliation: Mother & Child Health Institute, Belgrade, Serbia.
authors.forename: Srdjan
authors.initials: S
authors.lastname: Pasic
authors.affiliation: University of Texas Southwestern Medical Center and Children's Medical Center, Children's Health, Dallas, Tex.
authors.forename: Victor
authors.initials: V
authors.lastname: Aquino
authors.affiliation: University of Texas Southwestern Medical Center and Children's Medical Center, Children's Health, Dallas, Tex.
authors.forename: Christian
authors.initials: C
authors.lastname: Wysocki
authors.affiliation: Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Hassan
authors.initials: H
authors.lastname: Abolhassani
authors.affiliation: UC San Francisco, San Francisco, Calif.
authors.forename: Morna
authors.initials: M
authors.lastname: Dorsey
authors.affiliation: Mount Sinai Hospital, New York, NY.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Cunningham-Rundles
authors.affiliation: Saint Louis University, St Louis, Mo.
authors.forename: Alan P
authors.initials: AP
authors.lastname: Knutsen
authors.affiliation: Duke University, Durham, NC.
authors.forename: John
authors.initials: J
authors.lastname: Sleasman
authors.affiliation: Division of Allergy-Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil.
authors.forename: Beatriz Tavares
authors.initials: BT
authors.lastname: Costa Carvalho
authors.affiliation: Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
authors.forename: Antonio
authors.initials: A
authors.lastname: Condino-Neto
authors.affiliation: Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Eyal
authors.initials: E
authors.lastname: Grunebaum
authors.affiliation: University of Oxford, Oxford, United Kingdom.
authors.forename: Helen
authors.initials: H
authors.lastname: Chapel
authors.affiliation: University of Washington and Seattle Children's Research Institute, Seattle, Wash.
authors.forename: Hans D
authors.initials: HD
authors.lastname: Ochs
authors.affiliation: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Filipovich
authors.affiliation: UC San Francisco, San Francisco, Calif.
authors.forename: Mort
authors.initials: M
authors.lastname: Cowan
authors.affiliation: Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
authors.forename: Andrew
authors.initials: A
authors.lastname: Gennery
authors.affiliation: Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
authors.forename: Andrew
authors.initials: A
authors.lastname: Cant
authors.affiliation: Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Md.
authors.forename: Luigi D
authors.initials: LD
authors.lastname: Notarangelo
authors.affiliation: Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Chaim M
authors.initials: CM
authors.lastname: Roifman
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000401:mortality*; D006801:Humans; D053306:Hyper-IgM Immunodeficiency Syndrome / Q000401:mortality* / Q000628:therapy*; D007223:Infant; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D013995:Time; D055815:Young Adult
keywords: CD40 ligand; Karnofsky/Lansky scores; X-linked hyper-IgM syndrome; defects in class-switch recombination; hematopoietic cell transplantation; long-term outcomes; primary immunodeficiency